CEO of vaccine alliance GAVI Seth Berkley talks on the state of the pandemic at the World Economic Forum in Davos, Switzerland, Jan 18, 2023. (PHOTO / AP)
Global vaccine alliance GAVI said on Wednesday that 12 countries in Africa would receive 18 million doses of malaria vaccine over the next two years, expanding access to the shots to nine new countries in the region.
Malaria remains one of the continent's deadliest diseases, killing nearly half a million children each year under the age of five. In 2021, Africa accounted for about 95 percent of global malaria cases and 96 percent of deaths, according to the World Health Organization.
The nine new countries set to receive the vaccine, developed by British drugmaker GSK, are Benin, Burkina Faso, Burundi, Cameroon, the Democratic Republic of the Congo, Liberia, Niger, Sierra Leone and Uganda
"At least 28 African countries have expressed interest in receiving the RTS,S (malaria) vaccine," WHO chief Tedros Adhanom Ghebreyesus said at a media briefing, adding that a second malaria vaccine was under review for pre-qualification and if successful, could provide additional supply in the short term.
ALSO READ: African nations to approve malaria shot, 20m doses ready
Ghana, Kenya and Malawi have been receiving the RTS,S vaccine since 2019 as part of a pilot program funded by GAVI and more than 1.7 million children in the countries have been dosed with it, GAVI, UNICEF and the WHO said in a joint statement.
The nine new countries set to receive the vaccine, developed by British drugmaker GSK, are Benin, Burkina Faso, Burundi, Cameroon, the Democratic Republic of the Congo, Liberia, Niger, Sierra Leone and Uganda.
READ MORE: Ghana first to approve Oxford's malaria vaccine
The first doses of the RTS,S vaccine are expected to reach the 12 African countries during the last quarter of 2023, allowing them to start rolling out by early next year.
